Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Get your white paper about current therapies in Immuno-oncology
labiotech-a-guide-1920x400.jpg
Guide

Get your white paper about current therapies in Immuno-oncology

A single White Paper for a review of immuno-oncology

Immuno-oncology, the field which stimulates a individual's own immunity in order to fight cancer, has seen major advances since the 19th century and is now one of the most promising approaches against cancer.

This White Paper provides you with relevant information related to:

  • Immuno-oncology history
  • Passive therapies - review
  • Active therapies - review
  • Immuno-oncology’s future

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

* が付いているフィールドは入力必須です
お客様は個人データを送信することにより、Revvity Inc. およびその関連会社(以下「当社」)が、当社のプライバシーポリシー(ご覧になるにはこちらをクリック)に従って上記で提供されたお客様の個人データを処理することに同意するものとします。

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Download Resource

Get your white paper about current therapies in Immuno-oncology

Download Guide
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.